Bioactive dietary peptides and amino acids in inflammatory bowel disease

Amino Acids

Volumn 47, Issue 10, 2015, Pages 2127-2141

  Zhang, Hua ^a   Hu, Chien An A ^b   Kovacs Nolan, Jennifer ^a   Mine, Yoshinori ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Amino acids; Apoptosis; Autophagy; CasR; Dietary peptides; Inflammatory bowel disease

Indexed keywords

AMINO ACID; AZATHIOPRINE; CALCIUM SENSING RECEPTOR; CORTICOSTEROID; INFLIXIMAB; MERCAPTOPURINE; OLIGOPEPTIDE; PEPTIDE; PREBIOTIC AGENT; PROBIOTIC AGENT; PEPTIDE FRAGMENT;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; DIET SUPPLEMENTATION; DISEASE SEVERITY; EGG YOLK; ENTERITIS; EXPERIMENTAL MODEL; HUMAN; IMMUNE RESPONSE; INFLAMMATORY BOWEL DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SOY FOOD; ANIMAL; DIET; INFLAMMATORY BOWEL DISEASES; METABOLISM;

AMINO ACIDS; ANIMALS; DIET; HUMANS; INFLAMMATORY BOWEL DISEASES; PEPTIDE FRAGMENTS;

EID: 84942505905     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-014-1886-9     Document Type: Article

References (109)

1. Adibi SA (1997) The oligopeptide transporter (Pept-1) in human intestine: biology and function. Gastroenterology 113:332-340
2. Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev 3:745-756
3. Ajibade AA, Wang Q, Cui J, Zou J, Xia X, Wang M et al (2012) TAK1 negatively regulates NF-kB and p38 MAP kinase activation in Gr-1 + CD11B + neutrophiles. Immunity 36:43-54
4. Bailey M, Haverson K (2006) The postnatal development of the mucosal immune system and mucosal tolerance in domestic animals. Vet Res 37:443-453
5. Bassaganya-Riera J, Hontecillas R (2006) CLA and n-3 PUFA differentially modulate clinical activity and colonic RRAR-responsive gene expression in a pig model of experimental IBD. Clinical Nutrition 25:454-465
6. Baud V, Karin M (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11:372-377
7. Baumgart DC, Sandborn WJ (2007) Gastroenterology 2: Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369:1641-1657
8. Beutheu S, Ghouzali I, Galas L, Dechelotte P, Coeffier M (2013) Glutamine and arginine improve permeability and tight junction protein expression in methotrexate-treated Caco-2 cells. Clin Nutri 32:863-869
9. Born M, Bouma G (2004) Animal models of inflammatory bowel diseases. Drug Discov Today: Disease Models 1:437-443
10. Bouwmeester T, Bauch A, Ruffner H, Angrand P, Bergamini G, Croughton K et al (2004) A physical and functional map of the human TNF-a/NF-kB signal transduction pathway. Nat Cell Biol 6:97-105
11. Brandtzaeg P, Carlsen HS, Halstensen TS (2006) The B-cell system in inflammatory bowel diseases. Adv Exp Med Biol 579:149-167
12. Breese EJ, Michie CA, Nicholls SW, Murch SH, Williams CB, Domizio P (1994) Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 106:1455-1466
13. Bresalier RS (1999) Calcium, chemoprevention, and cancer: a small step forward (a long way to go). Gastroenterology 116:1261-1263
14. Brown EM, MacLeod RJ (2001) Extacellular calcium sensing and etracellular calcium signaling. Physiol Rev 81:239-297
15. Casteel SW, Cowart RP, Weis CP, Henningsen GM, Hoffman E, Brattin WJ et al (1996) A swine model for determining the bioavailability of lead from contaminated media. In: Tumbleson ME, Schook LB (eds) Advances in swine in biomedical research. Plenum Press, New York, pp 637-646
16. CDC (2011) US Centers for Disease Prevention and Control. http://www.cdc.gov/ibd/. Accessed 6 Feb 2013
17. Chakrabarty S, Radjendirane v, Appelman H, Varani J (2003) Extracellular calcium and calcium sensing receptor function in human colon carcinomas promotion of E-cadherin expression and suppression of catenin/TCF activation. Cancer Res 6:67-71
18. Chapkin RS, Davidson LA, Ly L, Weeks BR, Lupton JR, McMurray DN (2007) Immunomodulatory effects of (n-3) fatty acids: putative link to inflammation and colon cancer. J Nutri 134:200S-204S
19. Charerntantanakul W, Roth JA (2007) Biology of procine T lymphocytes. Anim Health Res Rev 7:81-89
20. Chen HM, Muramoto K, Yamauchi F (1995) Stuctural analysis of antioxidative peptides from soybean beta-conglycinin. J Agri Food Chem 43:574-578
21. Chen HM, Muramoto K, Yamauchi F, Fujimoto K, Nokihara K (1998) Antioxidative activity of designed peptides based on the antioxidative peptide isolated from digests of a soybean peptide. J Agric Food Chem 46:49-53
22. Cho JH (2006) Finding inflammatory bowel disease genes will lead to a cure. Can J Gastroenterol 20:641-642
23. Conigrave AD, Brown EM (2006) Taste receptors in the gastrointestinal tract II L-amino acid sensing by calcium-sensing receptors implications for GI physiology. Am J Physiol Gastrointest Liver Physiol 291:G753-G761
24. Daniel H, Kottra G (2004) The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Eur J Physiol 447:610-618
25. de Silva S, Devlin S, Panaccione R (2010) Optmizing the safety of biologic therapy for IBD. Nat Rev Gastroenterol Hepatol 7:93-101
26. Deventer SJ (1997) Tumour necrosis factor and Crohn's disease. Gut 40:443-448
27. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK (2007) Beta-arrestins and cell signaling. Ann Rev Physiol 69:483-510
28. Disilvestro RA (2001) Flavonoids as antioxidants. In: Wildman RE (ed) Handbook of nutraceuticals and functional foods. CRC Press, Boca Raton, pp 127-142
29. Elias RJ, Kellerby SS, Decker EA (2008) Antioxidant activity of proteins and peptides. Crit Rev Food Sci Nutr 48:430-441
30. Fan H, Luttrell LM, Tempel GE, Senn JJ, Halushka PV, Cook JA (2007) beta-arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression. Mol Immunol 44:3092-3099
31. Faure M, Mettraux C, Moennoz D, Godin J, Vuichoud J, Rochat F et al (2006) Specific amino acids increase mucin synthesis and microbiota in dextran sulfate sodium-treated rats. J Nutr 136:1558-1564
32. Fillmann H, Kretzmann NA, San-Miguel B (2007) Glutamine inhibits over-expression of pro-inflammatory genes and down-regulates the nuclear factor kappaB pathway in an experimental model of colitis in the rat. Toxicology 236:217-226
33. Fossum C (1998) Cytokines as markers for infections and their effect on growth performance and well-being in the pig. Domest Anim Endocrinol 5:439-444
34. Fuss IJ, Neurath M, Boirivant M et al (1996) Disparate CD4+ lamnia propria (LP) lymphokine secretion profiles in inflammatory bowel disease Crohn's disease LP cells manifest increased secretion of INF-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 157:1261-1270
35. Gao II, Sun Y, Wu Y, Luan B, Wang Y, Qu B et al (2004) Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kB pathways. Mol Cell 14:303-317
36. Gill HS, Doull F, Rutherfurd KJ, Cross ML (2000) Immunoregulatory peptides in bovine milk. Br J Nutr 84:S111-S117
37. Grell M (1995) Tumor necrosis factor (TNF) receptors in cellular signaling of soluble and membrane-expressed TNF. J Inflamm 47:8-17
38. Hebert SC, Cheng S, Geibel J (2004) Functions and roles of the extracellular Ca2+-sensing receptor in the gastrointestinal tract. Cell Calcium 35(3):239-247
39. Hofer AM, Brown EM (2003) Extracellular calcium sensing and signalling. Nat Rev/Mol Cell Biol 4:530-538
40. Hommes D, Baer F, van Assche G et al (2006) The ideal management of Crohn's disease: top down versus step up strategies: a randomized controlled trial. Gastroenterology 130:A108
41. Hou Y, Chu C, Ko T, Yeh C, Yeh S (2013) Effects of alanyl-glutamine dipeptide on the expression of colon-inflammatory mediators during the recovery phase of colitis induced by dextran sulfate sodium. Eur J Nutr 52:1089-1098
42. Inokuchi S, Aoyama T, Miura K, Osterreicher CH, Kodama Y, Miyai K et al (2010) Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis and carcinogenesis. PNAS 107:844-849
43. Iskandar MM, Dauletbaev N, Kubow S, Mawji N, Lands LC (2013) Whey protein hydrolysates decrease IL-8 secretion in lipopolysaccharide (LPS)-stimulated respiratory epithelial cells by affecting LPS binding to Toll-like receptor 4. Br J Nutr 3:1-11
44. Itakura E, Kishi-Itakura C, Mizushima N (2012) The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes. Cell 151:1256-1269
45. Jobin C, Holt L, Bradham CA, Streetz K, Brenner DA, Sartor RB (1999) TNF receptor-associated factor-2 is involved in both IL-1beta and TNF-alpha signaling cascades leading to NF-kappaB activation and IL-8 expression in human intestinal epithelial cells. J Immunol 162:4447-4454
46. Johnson IT (2001) New food components and gastrointestinal health. Proc Nutr Soc 60:481-488
47. Jurjus AR, Khoury NN, Reimund J (2004) Animal models of inflammatory bowel disease. J Pharmacol Toxicol Methods 50:81-92
48. Kajino-Sakamoto R, Inagaki M, Lippert E, Akira S, Robine S, Matsumoto K et al (2008) Enterocyte-derived TAK1 signaling prevents epithelium apoptosis and the development Ileitis and colitis. J Immunol 181:1143-1158
49. Kanayama A, Inoue J, Sugita-Konishi Y, Shimizu M, Miyamoto Y (2002) Oxidation of IκBα at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-κB activation. J Biol Chem 277:24049-24056
50. Katayama S, Mine Y (2007) Antioxidative activity of amino acids on tissue oxidative stress in human intestinal epithelial cell model. J Agric Food Chem 17:8458-8464
51. Katayama S, Xu X, Fan MZ, Mine Y (2006) Antioxidative stress activity of oligophosphopeptides derived from hen egg yolk phosvitin in Caco-2 cells. J Agric Food Chem 54:773-778
52. Katayama S, Ishikawa S, Fan MZ, Mine Y (2007) Oligophosphopeptides derived from egg yolk posvitin up-regulate gamma-glutamlcysteine synthetase and antioxidant enzymes aginst oxidative stress in Caco-2 cells. J Agric Food Chem 55:2829-2835
53. Kim CJ, Kovacs-Nolan J, Yang C, Archbold T, Fan MZ, Mine Y (2009a) L-cysteine supplementation attenuates local inflammation and restores gut homeostasis in a porcine model of colitis. Bionchim Biophys Acta 1790:1161-1169
54. Kim J, Kajino-Sakamoto R, Omori E, Jobin C, Ninomiya-Tsuji J (2009b) Intestinal epithelial-derived TAK1 signaling is essential for cytoprotection against chemical-induced colitis. PLoS One 4:e4561-e4571
55. Kim CJ, Kovacs-Nolan JA, Yang C, Archbold T, Fan MZ, Mine Y (2010) L-Tryptophan ehibits therapeutic function in a porcine model of dextran sodium sulfate (DSS)-induced colitis. J Nutr Biochem 21:468-475
56. Kovacs-Nolan J, Zhang H, Ibuki M, Nakamori T, Yoshiura K, Turner PV et al (2012) The PepT1-transportable soy tripeptide VPY reduces intestinal inflammation. Biochim Biophys Acta 1820:1753-1763
57. Kovacs-Nolan J, Rupa P, Matsui T, Tanaka M, Konishi T, Sauchi Y, Sato K, Ono S, Mine Y (2014) In vitro and ex vivo uptake of glutathione (GSH) across the intestinal epithelium and fate of oral GSH after in vivo supplementation. J Agric Food Chem 62:9499-9506
58. Kretzmann NA, Fillmann H, Mauriz JL, Marroni CA, Marroni A, Gonzalez-Gallego J et al (2008) Effects of glutamine on proinflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in TNBS-induced colitis. Inflamm Bowel Dis 14(11):1504-1513
59. Li YW, Li B (2013) Characterization of structure-antioxidant activity relationship of peptides in free radical systems using QSAR models: key sequence positions and their amino acid properties. J Theor Biol 318:29-43
60. Lih-Bordy L, Powell SR, Collier KP, Reddy GM (1996) Increased oxidavtive stress and decreased antioxidand defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 41:2078-2086
61. Liu Q, Busby JG, Molkentin JD (2009) Interaction between TAK1-TAB 1-TAB 2 and RCAN1-calcineurin defines a signalling nodal control point. Nat Cell Biol 11:154-161
62. Macarthur M, Hold GL, EI-Omar EM (2004) Inflammation and cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 286:G515-G520
63. Meria LB, Ugni JM, Green SL, Lee C, Pang B, Borenshtein D et al (2008) DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest 118:2516-2525
64. Mizoguchi A (2012) Animal models of inflammatory bowel disease. Prog Mol Biol Transl Sci 105:263-319
65. Moffett JR, Namboodiri MA (2003) Tryptophan and the immune response. Immunol Cell Biol 81:247-265
66. Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev/Cancer 2(8):584-593
67. Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K (1999) The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398:252-256
68. Ockenga GJ (2005) Glutamine-enriched total parenteral nutrition in patients with inflammatory bowel disease. Eur J Clin Nutri 59:1302-1309
69. Ohsu T, Amino Y, Nagasaki H, Yamanaka T, Takeshita S, Hatanaka T et al (2010) Involvement of the calcium-sensing receptor in human taste perception. JBC 285:1016-1022
70. Omori E, Matsumoto K, Sanjo H, Sato S, Akira S, Smart RC et al (2006) TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosis. JBC 281:19610-19617
71. Othman M, Aguero R, Lin HC (2008) Alterations in intestinal microbial flora and human disease. Curr Opin Gastroenterol 24:11-16
72. Owenberg M, Peppelenbosch M, Hommes D (2006) Biological therapy in the management of recent-onset Crohn's Disease. Drugs 66:1431-1439
73. Oz HS, Chen TS, McClain CJ, de Villiers WJ (2005) Antioxidants as novel therapy in a murine model of colitis. J Nutr Biochem 16:297-304
74. Pache I, Rogler G, Felley C (2009) TNF-alph blockers in inflammatory bowel diseases: practical consensus, recommendations and a user's guid. Swiss Med WKLY 139:278-287
75. Pacheco II, MacLeod RJ (2008) CaSR stimulates scretion of Wnt5a from colonic myofibroblasts to stimulate CDX2 and sucrase-isomaltase using Ror2 on intestinal epithelia. Am J Physiol Gastrointest Liver Physiol 295:G748-G759
76. Pan M, Lai C, Ho C (2010) Anti-inflammatory activity of natural dietary flavonoids. Food Funct. 1:15-31
77. Papa A, Mocci G, Scaldaferri F, Bonizzi M, Felice C, Anderisani G et al (2009) New therapeutic approach in inflammaory bowel disease. Eur Rev Med Pharmacol Sci 13:33-35
78. Papadakis KA, Targan SR (2000) Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 51:289-298
79. Pena-Ramos EA, Xiong YL (2001) Anitoxidative activity of whey protein hydrolysates in a liposomal system. J Dairy Sci 84:2577-2583
80. Pierce KL, Lefkowitz RJ (2001) Classical and new roles of beta-arrestins in the regulation of G-protein-coupled receptors. Nat Rev 2:727-733
81. Quinn SJ, Ye C, Diaz R, Kifor O, Bai M, Vassilev P et al (1997) The Ca2+-sensing receptor: a target for polyamines. Am J Physiol Cell Physiol 273:C1315-C1323
82. Reeds P, Odle J (1996) Pigs as models for nutrient functional interaction. In: Tumbleson ME, Schook LB (eds) Advances in swine in biomedical research. Plenum Press, New York, pp 709-711
83. Ronchi VP, Giudici AM, Mendieta JR, Caballero VJ, Chisari AN, Sanllorenti PM et al (2010) Oxidative stress in mouse liver caused by dietary amino acid deprivation: protective effect of methionine. J Physiol Biochem 66:93-103
84. Royall D, Jeejeebhoy KN, Baker JP, Allard JP, Habal FM, Cunnane SC et al (1994) Comparison of amino acid vs peptide based enteral diets in active Crohn's disease: clinical and nutritional outcome. Gut 35:783-787
85. Saito K, Jin DH, Ogawa T, Muramoto K, Hatakeyama E, Yasuhara T et al (2003) Antioxidative properties of tripeptide libraries prepared by the combinatorial chemistry. J Agric Food Chem 51:3668-3674
86. Sakiyama T, Musch MW, Ropeleski MJ, Tsubouchi H, Chang EB (2009) Glutamine increases autophagy under basal and stressed conditions in intestinal epithelial cells. Gastroenterology 136:924-932
87. Sartor RB (2006) Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3:390-407
88. Sartor RB (2007) Microbial and dietary factors in the pathogenesis of chronic, immune-mediated intestinal inflammation. In: Blumberg RS, Neurath MF (eds) Immune mechanisms in inflammatory bowel disease. Springer, New York, p 35
89. Shimizu M (2004) Food-derived peptides and intestinal functions. Biofactors 21:43-47
90. Sipos W, Duvigneau JC, Willheim M, Schilcher F, Hartl RT, Hofbauer G (2004) Systemic cytokine profile in feeder pigs suffering from natural postweaning mutisystemic wasting sydrome (PMWS) as determined by semiquanitiative RT-PCR and flow cytometric intracellular cytokine detection. Vet Immunol Immunopathol 99:63-71
91. Son M, Ko JI, Kim WB, Jang HK, Kim BK (1998) Taurine can ameliorate inflammatory bowel disease in rats. Adv Exp Med Biol 442:291-298
92. Son DO, Satsu H, Shimizu M (2005) Histidine inhibits oxidative stress- and TNF-alpha-induced interleukin-8 secretion in intestinal epithelial cells. FEBS Lett 579:4671-4677
93. Son DO, Satsu H, Kiso Y, Totsuka M, Shimizu M (2008) Inhibitory effect of carnosine on interleukin-8 production in intestinal epithelial cells through translational regulation. Cytokine 42:265-276
94. Suchner U, Kuhn KS, Furst P (2000) The scientific basis of immunonutrition. Proc Nutr Soc 59:553-563
95. Suetsuna K, Ukeda H, Ochi H (2000) Isolation and characterizaton of free radical scavenging activities peptides derived from casein. J Nutri Biochem 11:128-131
96. Sundaram U, Wisel S, Coon S (2007) Neutral Na-amino acid cotransport is differentially regulated by glucocorticoids in the normal and chronically inflamed rabbit small intestine. Am J Physiol Gastrointest Liver Physiol. 292(2):G467-G474
97. Te Velde AA, Verstege MI, Hommes DW (2006) Critical appraisal of the current practive in murine TNBS-induced colitis. Inflamm Bowel Dis 12:995-999
98. Teahon K, Smethurst P, Pearson M, Levi AJ, Bjarnason I (1991) The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease. Gastronenterology 101:84-89
99. Terzic J, Grivennikov S, Karin E, Karin M (2010) Inflammation and colon cancer. Gastroenterology 138:2101-2114
100. van Deventer SJ (1999) Anti-TNF antibody treatment of Crohn's disease. Ann Rheum Dis 58:1114-1120
101. van Dullemen HM, van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Tytgat GN, Woody J (1995) Treatment of Crohn's Disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109(1):129-135
102. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ (2001) TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412:346-351
103. Wang M, Yao Y, Huang D, Hampson DR (2006a) Activation of family C G-protein-coupled receptors by the tripeptide glutathione. J Biol Chem 281:8864-8870
104. Wang Y, Tang Y, Teng L, Wu Y, Zhao X, Pei G (2006b) Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin1 receptor signaling. Nat Immunol 7:139-147
105. Wang Y, Chandra R, Samsa LA, Gooch B, Fee BE, Cook JM et al (2011) Amino acids stimulate cholecystokinin release through the Ca2+-sensing receptor. Am J Physiol Gastrointest Liver Physiol 300:G528-G537
106. Witherow DS, Garrison TR, Miller WE, Lefkowitz RJ (2004) beta-arrestin inhibits NF-kB activity by means of its interaction with the NF-kB inhibitor IkBa. Proc Natl Acad Sci USA 101:8603-8607
107. Wolf AM, Wolf D, Rumpold H, Moschem AR, Kaser A, Obrist P et al (2004) Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. Clin Immunol 113:47-55
108. Yamamoto T (2013) Nutrition and diet in inflammatory bowel disease. Curr Opin Gastroenterol 29:216-221
109. Young D, Ibuki M, Nakamori T, Fan M, Mine Y (2012) Soy-derived di- and tripeptides alleviate colon and ileum inflammation in pigs with dextran sodium sulfate-induced colitis. J Nutri 142:363-368